Senti Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	10.48	35.93	57.62	56.03	30.54	5.3
Short-Term Investments	-	0.04	42.15	1.16	0.03	12.53
Cash & Short-Term Investments	10.48	35.97	99.77	57.19	30.56	17.83
Cash Growth	-73.86%	-63.95%	74.45%	87.13%	71.42%	-
Accounts Receivable	0.07	0.11	0.63	0.48	0.32	0.08
Other Receivables	1.11	17.59	-	-	-	-
Receivables	1.19	17.7	0.63	0.48	0.32	0.08
Prepaid Expenses	5.72	17.33	1.87	0.8	-	0.85
Other Current Assets	-	0.2	0.31	1.72	0.83	-
Total Current Assets	17.38	71.2	102.58	60.19	31.71	18.76
Property, Plant & Equipment	36.69	41.61	69.78	33.08	16.14	16.59
Other Long-Term Assets	3.65	6.67	8.43	3.43	0.5	0.5
Total Assets	57.72	119.48	180.79	96.7	48.35	35.84
Accounts Payable	0.79	1.25	1.37	5.19	0.91	1.2
Accrued Expenses	2.98	5.93	12.58	5.33	2	1.71
Current Portion of Leases	4.59	4.13	1.99	1.74	1.52	1.24
Current Unearned Revenue	0.64	0.99	0.8	1.66	-	0.17
Other Current Liabilities	0.07	0.38	1.32	0.63	0.44	-
Total Current Liabilities	9.06	12.67	18.05	14.54	4.87	4.31
Long-Term Leases	30.12	33.54	35.1	20.99	12.53	13.57
Long-Term Unearned Revenue	-	-	-	0.18	-	-
Other Long-Term Liabilities	2.54	6.36	0.37	0.62	-	-
Total Liabilities	41.73	52.57	53.53	36.33	17.4	17.88
Common Stock	0	0.01	0	-	0	0
Additional Paid-In Capital	312.52	311.25	300.54	3.62	1.04	0.44
Retained Earnings	-296.52	-244.34	-173.29	-115.08	-59.76	-39.9
Comprehensive Income & Other	-	-	0	-	-	0.01
Total Common Equity	15.99	66.91	127.26	-111.46	-58.71	-39.44
Shareholders' Equity	15.99	66.91	127.26	60.38	30.95	17.97
Total Liabilities & Equity	57.72	119.48	180.79	96.7	48.35	35.84
Total Debt	34.71	37.67	37.09	22.73	14.05	14.81
Net Cash (Debt)	-24.23	-1.7	62.68	34.46	16.51	3.02
Net Cash Growth	-	-	81.89%	108.68%	446.97%	-
Net Cash Per Share	-5.33	-0.38	24.01	118.33	11.91	2.22
Filing Date Shares Outstanding	4.59	4.57	4.42	1.52	1.45	1.36
Total Common Shares Outstanding	4.59	4.57	4.41	1.52	1.45	1.36
Working Capital	8.32	58.53	84.53	45.65	26.84	14.45
Book Value Per Share	3.49	14.64	28.88	-73.38	-40.48	-29.03
Tangible Book Value	15.99	66.91	127.26	-111.46	-58.71	-39.44
Tangible Book Value Per Share	3.49	14.64	28.88	-73.38	-40.48	-29.03
Machinery	-	8.87	8.56	5.54	3.91	3.34
Construction In Progress	-	-	43.89	8.05	0.23	-
Leasehold Improvements	-	22.65	1.87	0.43	0.16	0.15

Source: S&P Capital IQ. Standard template. Financial Sources.